Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 870 | 590 | 850 | 860 | 1,460 |
| Receivables | 320 | 340 | 490 | 440 | 500 |
| Other current assets | 70 | 40 | 100 | 140 | 40 |
| TOTAL | $1,260 | $970 | $1,440 | $1,440 | $2,000 |
| Non-Current Assets | |||||
| PPE Net | 30 | 40 | 70 | 50 | 100 |
| Other Non-Current Assets | 160 | 190 | 228 | 251 | 340 |
| TOTAL | $190 | $230 | $298 | $301 | $440 |
| Total Assets | $1,460 | $1,200 | $1,740 | $1,750 | $2,450 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 70 | 20 | 30 | 10 | 50 |
| Accrued Expenses | 130 | 110 | 160 | 110 | 160 |
| Other current liabilities | 390 | 0 | 0 | 100 | 250 |
| TOTAL | $660 | $170 | $310 | $340 | $800 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 70 | 0 | 0 | 0 |
| TOTAL | $N/A | $70 | $N/A | $N/A | $N/A |
| Total Liabilities | $660 | $240 | $310 | $340 | $800 |
| Shareholders' Equity | |||||
| Common Shares | 470 | 470 | 470 | 470 | 470 |
| Retained earnings | -46,100 | -45,940 | -45,440 | -45,460 | -45,220 |
| TOTAL | $790 | $950 | $1,430 | $1,410 | $1,650 |
| Total Liabilities And Equity | $1,450 | $1,190 | $1,740 | $1,750 | $2,450 |